Startup Metfora, LLC is the recipient of a Small Business Innovation Research (SBIR) Phase l Award from the NSF to pursue the detection of chronic diseases via multiplex analysis of circulating metabolites. They will receive a one-year grant of $255,706 to expand a diagnostic technology developed at the UArizona College of Medicine – Tucson.

The United States ranks 25th out of 37 nations in mathematics literacy as listed by the Organization for Economic Co-operation and Development (OECD). Systems Engineering Professor Ricardo Valerdi came up with a solution that's now impacting hundreds of thousands of students around the nation.

With help from Tech Launch Arizona, TheraCea was launched in 2020 to develop diagnostic agents that allow oncologists and pharmaceutical companies to select the right segment of patients who will be responsive to specific immunotherapy drugs.

UArizona researchers have been developing a new compound that inhibits SARS-CoV-2, the virus that causes COVID-19. The university has now exclusively licensed the technology to Sunshine Biopharma Inc. to take forward for further development and testing.